Curanex Pharmaceuticals
CURX
NASDAQ
IPO2025
about CURX
Curanex Pharmaceuticals is a developmental-stage biopharmaceutical company that focuses on discovering and developing botanical drugs, with their lead product candidate, Phyto-N, being developed to treat inflammatory diseases like ulcerative colitis.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $6.05 | $7.29 | $6.00 | $197.03M | 3.99M |